Hpgc Renmintongtai Pharmaceutical Corporation Class ASSE: 600829

Report for Q1 2025

Apr 19, 2025 · Issued by Hpgc Renmintongtai Pharmaceutical Corporation Class A via Shanghai Stock Exchange

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment